Karen A Dawes Repligen Corp (RGEN) insider trading activity

Karen A Dawes is of REPLIGEN CORP. Currently has a direct ownership of 88,170 shares of RGEN, which is worth approximately $12.7 Million. The most recent transaction as insider was on Jun 14, 2024, when has been sold 2,953 shares (Common Stock) at a price of $67.71 per share, resulting in proceeds of $199,947. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 88.2K

0% 3M change

5.29% 12M change

Total Value Held $12.7 Million

KAREN A DAWES Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 14 2024	BUY Exercise of conversion of derivative security	$199,947 $67.71 p/Share	2,953 Added 3.24%	88,170 Common Stock
May 16 2024	BUY Grant, award, or other acquisition	-	803 Added 0.9%	88,170 Common Stock
Feb 27 2024	SELL Open market or private sale	$193,350 $193.35 p/Share	1,000 Reduced 1.13%	87,367 Common Stock
Feb 27 2024	BUY Exercise of conversion of derivative security	$194,615 $42.07 p/Share	4,626 Added 4.97%	88,367 Common Stock
Aug 29 2023	SELL Open market or private sale	$145,673 $171.38 p/Share	850 Reduced 1.0%	83,741 Common Stock
Aug 29 2023	BUY Exercise of conversion of derivative security	$133,943 $18.12 p/Share	7,392 Added 8.04%	84,591 Common Stock
May 18 2023	BUY Grant, award, or other acquisition	-	798 Added 1.02%	77,199 Common Stock
Sep 09 2022	SELL Open market or private sale	$176,057 $227.17 p/Share	775 Reduced 1.0%	76,401 Common Stock
May 26 2022	BUY Grant, award, or other acquisition	-	644 Added 0.83%	77,176 Common Stock
May 25 2022	SELL Open market or private sale	$2,223,437 $151.1 p/Share	14,715 Reduced 16.13%	76,532 Common Stock
Nov 10 2021	SELL Open market or private sale	$1,268,212 $265.15 p/Share	4,783 Reduced 4.98%	91,247 Common Stock
Nov 10 2021	SELL Exercise of conversion of derivative security	$124,932 $26.12 p/Share	4,783 Reduced 4.74%	96,030 Common Stock
Nov 02 2021	SELL Open market or private sale	$727,656 $303.19 p/Share	2,400 Reduced 2.56%	91,247 Common Stock
Sep 14 2021	SELL Open market or private sale	$80,405 $293.45 p/Share	274 Reduced 0.29%	93,647 Common Stock
Sep 01 2021	SELL Open market or private sale	$978,966 $283.02 p/Share	3,459 Reduced 3.55%	93,921 Common Stock
Sep 01 2021	SELL Exercise of conversion of derivative security	$134,071 $38.76 p/Share	3,459 Reduced 3.43%	97,380 Common Stock
Aug 18 2021	SELL Open market or private sale	$363,609 $259.35 p/Share	1,402 Reduced 1.47%	93,961 Common Stock
Aug 18 2021	BUY Open market or private sale	$10,492 $262.31 p/Share	40 Added 0.04%	93,921 Common Stock
Aug 17 2021	SELL Open market or private sale	$4,442,776 $253.67 p/Share	17,514 Reduced 15.52%	95,363 Common Stock
Jul 20 2021	SELL Open market or private sale	$924,749 $201.69 p/Share	4,585 Reduced 3.9%	112,877 Common Stock
Jul 13 2021	BUY Open market or private sale	$307,390 $202.23 p/Share	1,520 Added 1.28%	117,462 Common Stock
Jul 13 2021	BUY Exercise of conversion of derivative security	$120,646 $41.19 p/Share	2,929 Added 2.4%	118,982 Common Stock
May 13 2021	BUY Grant, award, or other acquisition	-	604 Added 0.52%	116,053 Common Stock
May 11 2021	SELL Open market or private sale	$50,402 $176.85 p/Share	285 Reduced 0.25%	115,449 Common Stock
May 11 2021	BUY Exercise of conversion of derivative security	$48,300 $3.22 p/Share	15,000 Added 11.47%	115,734 Common Stock

Also insider at

VACC

Vaccitech plc Healthcare

Director

KAD

Karen A Dawes

Waltham, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RGEN shares.

Notify only if

Value

Insider Trading

Get notified when an Repligen Corp insider buys or sells RGEN shares.

Notify only if

Operation

Value

Type

News

Receive news related to REPLIGEN CORP

Track Activities on RGEN

Account